<b> Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved </b> <br/> <b>Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships </b><b/> <br/> <br/> HONG KONG SAR - EQS Newswire - 27 March 2023 - A fully integrated biopharmaceutical company – <b>Uni-Bio Science Group Limited</b> ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2022 (the "Year").
DJ Uni-Bio Science Group Limited: 2022 Annual Results EQS Newswire / 27/03/2023 / 22:00 UTC+8 Record High Turnover of HKUSD440.3 Million and HKUSD38.5 Million Profit Achieved Expanding
EQS Newswire / 27/03/2023 / 22:00 UTC+8Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships [27 March 2023 – Hong Kong] A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio.
Uni-Bio Science Group Limited Announces 2022 Annual Results livenews.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livenews.co.nz Daily Mail and Mail on Sunday newspapers.
EQS-News / 22/03/2022 / 08:00 UTC+8 Achieved Record-High Turnover and EGF Products Recorded Strong ReboundSuccessful Expansion Into Ophthalmology and Other Potential Therapeutic Areas [21 March 2022 - Hong Kong] A fully integrated biopharmaceutical company - Uni-Bio Science Group Limited ("Uni-Bio Science".